Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation | Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Phase 4 | 2026-10-01 | NCT04642430 | |
| AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia | Community-Acquired Infections, Community-Acquired Pneumonia, Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 3 | 2026-09-30 | NCT05848713 | |
| Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention | Embolism and Thrombosis, Thromboembolism, cardiovascular disorder, vascular disorder, venous thromboembolism | Not yet recruiting | Phase 3 | 2025-11-14 | NCT07228663 | |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy | Cancer of Urinary Tract, Embolism and Thrombosis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Thromboembolism, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, cardiovascular disorder, neoplasm, urinary system disorder, vascular disorder, venous thromboembolism | Recruiting | Phase 2 / Phase 3 | 2025-07-10 | NCT05920343 |